Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Security class unavailable · CUSIP: 53220K504
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,480,819
- Percent of class
- 6.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-19-000060
- Form type
- SC 13G
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Feb 12, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership